Form 8-K - Current report:
SEC Accession No. 0001437749-25-017239
Filing Date
2025-05-15
Accepted
2025-05-15 16:46:50
Documents
14
Period of Report
2025-05-15
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dmtp20250515_8k.htm   iXBRL 8-K 54908
  Complete submission text file 0001437749-25-017239.txt   190673

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA dmac-20250515.xsd EX-101.SCH 3579
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20250515_def.xml EX-101.DEF 11029
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20250515_lab.xml EX-101.LAB 14742
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20250515_pre.xml EX-101.PRE 11134
17 EXTRACTED XBRL INSTANCE DOCUMENT dmtp20250515_8k_htm.xml XML 2742
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36291 | Film No.: 25954658
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)